Second primary malignancies in thyroid cancer patients

The late health effects associated with radioiodine ((131)I) given as treatment for thyroid cancer are difficult to assess since the number of thyroid cancer patients treated at each centre is limited. The risk of second primary malignancies (SPMs) was evaluated in a European cohort of thyroid cance...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rubino, C, de Vathaire, F, Dottorini, M E, Hall, P, Schvartz, C, Couette, J E, Dondon, M G, Abbas, M T, Langlois, C, Schlumberger, M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2003
Assuntos:
Clinical
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2394426/
https://ncbi.nlm.nih.gov/pubmed/14583762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601319
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados